Bredia longiloba
What's the taxonomical classification of Bredia longiloba?
Bredia longiloba belongs to the kingdom Plantae and is classified within the phylum Streptophyta. As a member of the class Equisetopsida and the subclass Magnoliidae, it follows the evolutionary lineage of the order Myrtales. This species is further categorized under the family Melastomaceae, falling into the genus Bredia, and is specifically identified by its unique species name, longiloba.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Melastomataceae |
| Genus | Bredia |
| Species | longiloba |
What medicinal compounds this plant contains?
Bredia longiloba contains various bioactive secondary metabolites including alkaloids, flavonoids, tannins, and saponins that contribute to its pharmacological potential. These chemical constituents are primarily concentrated within the leaves and roots of the plant. Research suggests that these compounds may provide significant antioxidant and antimicrobial activities. Some studies also indicate that the plant possesses anti-inflammatory properties useful in traditional medicine. The specific concentration of these molecules can vary depending on the geographical location and environmental conditions of growth.
What are the therapeutic actions of Bredia longiloba?
What diseases this plant treats?
This plant is used to treat skin infections, wounds, stomach pains, and various inflammatory conditions. Its medicinal properties are primarily derived from the decoction of its bark or leaves. Local healers often apply crushed parts of the plant directly to sores to promote healing and prevent infection. Additionally, the plant is ingested in specific dosages to alleviate gastrointestinal discomfort and internal swelling. These traditional uses highlight its role in managing both topical and systemic ailments within certain communities.